PhysioTouch for Treatment of Radiation Fibrosis

Status Withdrawn

Clinical Trial Summary

A quarter of a million women will develop breast cancer (BC) in this year alone. Many of these women will have side effects as a result of their breast cancer treatment. Radiation Fibrosis Syndrome (RFS) is a common complication from breast cancer treatment that progressively changes tissue and can cause decreased function, pain, and range of motion. The PhysioTouch is a hand held device that can be used to treat RFS and may improve the treatment of fibrotic tissue. This pilot randomized controlled trial aims to determine the efficacy of using the PhysioTouch in addition to current standard of care for treatment of BC-related RFS.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03496909
Study type	Interventional
Source	University of Michigan
Contact
Status	Withdrawn
Phase	N/A
Start date	December 2018
Completion date	April 2020

View Details

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT00041223` - IH636 Grape Seed Extract in Treating Hardening of Breast Tissue in Women Who Have Undergone Radiation Therapy for Early Breast Cancer	Phase 2
Completed	`NCT00020631` - Pirfenidone in Treating Patients With Fibrosis Caused by Radiation Therapy for Cancer	N/A
Withdrawn	`NCT00880386` - Losartan in Treating Pulmonary Fibrosis in Patients With Stage I, II, or III Non-Small Cell Lung Cancer	N/A
Completed	`NCT00589121` - Image-Guided Radiation Therapy in Treating Patients With Primary Soft Tissue Sarcoma of the Shoulder, Arm, Hip, or Leg	Phase 2
Enrolling by invitation	`NCT05890196` - Autologous Fat Grafting in Radiated Soft Tissue Reconstruction
Enrolling by invitation	`NCT04992650` - Ultrasonic Perfusion Imaging in Post-mastectomy Irradiated Patients	N/A
Terminated	`NCT00077064` - Captopril in Treating Patients With Non-Small Cell Lung Cancer or Limited-Stage Small Cell Lung Cancer That Has Been Previously Treated With Radiation Therapy With or Without Chemotherapy	Phase 2
Recruiting	`NCT04485286` - Evaluation of PET Probe [68Ga]CBP8 in the Detection of Radiation Induced Tissue Injury	Phase 2
Completed	`NCT03462524` - Neoadjuvant Therapy for Esophageal Cancer and Cardiopulmonary Physiology	N/A
Active, not recruiting	`NCT00077090` - Hyperbaric Oxygen Therapy Compared With Standard Therapy in Treating Chronic Arm Lymphedema in Patients Who Have Undergone Radiation Therapy for Cancer	Phase 2